SymBio Pharmaceuticals Limited (TYO:4582)
69.00
-9.00 (-11.54%)
Nov 20, 2026, 3:30 PM JST
SymBio Pharmaceuticals Market Cap
SymBio Pharmaceuticals has a market cap or net worth of 5.83 billion as of November 20, 2026. It is the 31,831st most valuable company in the world and the 2,869th biggest in Japan. Its market cap has increased by 8.91% in one year.
Market Cap
5.83B
Enterprise Value
6.37B
Revenue
1.06B
Global Rank
Country Rank
#2,869 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 20, 2011, SymBio Pharmaceuticals's market cap has decreased from 7.08B to 5.83B, a decrease of -17.67%. That is a compound annual growth rate of -1.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 5.83B | 16.00% |
| Dec 30, 2025 | 5.02B | -44.92% |
| Dec 30, 2024 | 9.12B | -12.48% |
| Dec 29, 2023 | 10.42B | -58.97% |
| Dec 30, 2022 | 25.40B | -42.20% |
| Dec 30, 2021 | 43.94B | 203.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cawachi | 89.17B |
| YAKUODO HOLDINGS | 29.95B |
| Astena Holdings | 21.91B |
| Satudora Holdings | 17.23B |
| Medical System Network | 14.85B |
| Ohki Healthcare Holdings | 12.96B |
| Renascience | 11.67B |
| Pharmarise Holdings | 5.86B |